LABA-LAMA preferred over LABA-ICS inhalers for preventing COPD exacerbations | Latest news for Doctors, Nurses and Pharmacists | Respirology
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram
Optimizing asthma management: Role of long-acting muscarinic antagonists - ScienceDirect
Key findings of recent LAMA and dual-agent LAMA/LABA trials reviewed. | Download Table
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD | Pulmonary Therapy
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
![PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a56c4ea6ccc14edcd10985bf0259da67b0b0376/13-Figure1-1.png "PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar")
PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d | COPD
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic | COPD
Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
LABA/LAMA FDC or LABA/ICS FDC in patients with COPD | COPD
Medications To Prevent COPD Readmissions – What I've Learned As A Hospital Medical Director
Figure 4 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
asthma and COPD Flashcards | Quizlet
LAMA/LABA/ICS in einem Spray: Neue Dreifach-Fixkombi bei COPD
Copd 2017 | PPT
LABAs and LAMAs in development for combination therapies | Download Table
Choosing an inhaler for COPD made simple
LAMA plus LABA tied to fewer exacerbations in stable COPD
Frontiers | Single Inhaler LABA/LAMA for COPD
Implications of the GOLD COPD Classification and Guidelines | Federal Practitioner
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs | Cleveland Clinic Journal of Medicine
